Physician
Raleigh Group P.C.
Raleigh Group P.C. was paid $24.68M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 14% of everything it billed.
33Billing provider infoRALEIGH GROUP P.C.
MEMPHIS, TN 38128
MEMPHIS, TN 38128
33aNPI1831209873assigned 08/30/2006
33bProvider typePediatrics Physician
28Total paid$24.68M
24GClaims1,118,994
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#3 of 333
Median peer was paid$139K
This provider vs. median177×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 147,984 | $2.96M | |
| 2019 | 196,353 | $4.17M | |
| 2020 | 148,886 | $3.08M | |
| 2021 | 191,547 | $3.51M | |
| 2022 | 183,483 | $4.35M | |
| 2023 | 134,977 | $3.61M | |
| 2024incomplete | 115,764 | $3.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 50,216 | 44,840 | $3.52M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 69,979 | 63,588 | $3.26M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 79,414 | 70,248 | $3.11M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.4% | 30,328 | 27,821 | $2.32M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.1% | 29,943 | 26,830 | $2.24M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.2% | 21,570 | 18,916 | $1.79M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6.9% | 25,391 | 22,516 | $1.70M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.9% | 16,289 | 7,116 | $1.20M |
| 92552 | 4.5% | 67,513 | 59,985 | $1.11M | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 68,818 | 60,136 | $535K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.1% | 15,630 | 13,989 | $528K |
| 99173 | 1.6% | 67,534 | 60,044 | $401K |
104 more codes
| 96127 | 1.2% | 52,200 | $290K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 8,932 | $274K |
| 99401 | <1% | 10,065 | $235K | |
| 96160 | <1% | 11,343 | $214K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 9,451 | $193K |
| 99381 | <1% | 2,354 | $175K | |
| 96161 | <1% | 20,441 | $160K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,287 | $132K |
| 36416 | <1% | 69,664 | $124K | |
| 87428 | <1% | 2,328 | $120K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,403 | $114K |
| 90651 | <1% | 12,855 | $77K | |
| 81003 | <1% | 38,559 | $76K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 5,129 | $67K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,944 | $60K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,059 | $56K |
| 0071A | <1% | 1,315 | $50K | |
| 92522 | <1% | 2,586 | $42K | |
| 3008F | <1% | 74,724 | $40K | |
| 90734 | <1% | 5,900 | $38K | |
| 92567 | <1% | 2,255 | $35K | |
| 0072A | <1% | 919 | $34K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,363 | $30K |
| 0001A | <1% | 793 | $29K | |
| 87631 | <1% | 643 | $26K | |
| 0002A | <1% | 660 | $24K | |
| 99383 | <1% | 281 | $24K | |
| 0081A | <1% | 499 | $19K | |
| 90710 | <1% | 7,869 | $17K | |
| 90670 | <1% | 19,570 | $17K | |
| 0054A | <1% | 319 | $11K | |
| 69210 | <1% | 478 | $10K | |
| 0082A | <1% | 258 | $10K | |
| 90715 | <1% | 4,142 | $8K | |
| 99382 | <1% | 80 | $7K | |
| 81001 | <1% | 2,752 | $7K | |
| 90619 | <1% | 3,683 | $7K | |
| 90633 | <1% | 12,973 | $6K | |
| 90686 | <1% | 23,898 | $6K | |
| 90621 | <1% | 1,476 | $6K | |
| 90716 | <1% | 2,968 | $6K | |
| 0124A | <1% | 149 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,428 | $5K |
| 90696 | <1% | 3,145 | $5K | |
| 90680 | <1% | 14,081 | $5K | |
| 0154A | <1% | 120 | $5K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,276 | $5K |
| 99384 | <1% | 45 | $4K | |
| 90688 | <1% | 7,740 | $4K | |
| 0052A | <1% | 111 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 53 | $4K |
| 90677 | <1% | 3,244 | $4K | |
| 90480 | <1% | 98 | $4K | |
| 90697 | <1% | 6,022 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 257 | $3K |
| 90707 | <1% | 2,943 | $2K | |
| 96380 | <1% | 114 | $2K | |
| 90723 | <1% | 5,407 | $2K | |
| 94760 | <1% | 2,003 | $2K | |
| 90698 | <1% | 5,304 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 19 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 97 | $1K |
| 0051A | <1% | 31 | $1K | |
| 0173A | <1% | 28 | $1K | |
| 87634 | <1% | 51 | $1K | |
| 90648 | <1% | 8,076 | $898.76 | |
| 99462 | <1% | 35 | $817.22 | |
| 94200 | <1% | 60 | $735.00 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 32 | $646.89 |
| 90656 | <1% | 1,932 | $634.05 | |
| 90380 | <1% | 63 | $600.00 | |
| 94250 | <1% | 46 | $589.35 | |
| 85027 | <1% | 5,289 | $564.51 | |
| 0074A | <1% | 14 | $553.44 | |
| 90700 | <1% | 1,596 | $548.20 | |
| 94664 | <1% | 118 | $430.27 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 34 | $330.54 |
| 90623 | <1% | 174 | $276.00 | |
| 90473 | <1% | 19 | $226.30 | |
| 81025 | <1% | 46 | $209.97 | |
| 90744 | <1% | 1,218 | $122.74 | |
| 87420 | <1% | 30 | $100.83 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16 | $47.30 |
| 69209 | <1% | 20 | $15.29 | |
| 99080 | <1% | 1,742 | $14.00 | |
| 99000 | <1% | 17,536 | $8.61 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 47 | $6.33 |
| 99072 | <1% | 39,212 | $1.88 | |
| 91307 | 0% | 2,742 | $0.00 | |
| 91305 | 0% | 994 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 1,923 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 465 | $0.00 |
| 90674 | 0% | 366 | $0.00 | |
| 91315 | 0% | 146 | $0.00 | |
| 90381 | 0% | 15 | $0.00 | |
| 91317 | 0% | 56 | $0.00 | |
| 30999 | 0% | 30 | $0.00 | |
| 90687 | 0% | 215 | $0.00 | |
| 91308 | 0% | 1,030 | $0.00 | |
| 91300 | 0% | 1,695 | $0.00 | |
| 90661 | 0% | 268 | $0.00 | |
| 87400 | 0% | 62 | $0.00 | |
| 90685 | 0% | 627 | $0.00 | |
| 91312 | 0% | 196 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROLATER, CATHERINE (INSURANCE MANAGER)